Differential polymerase chain reaction and immunohistological studies on amplification and expression of cyclin D1 gene in human glioma tissues

Neuropathology

Volumn 18, Issue 3, 1998, Pages 270-275

  Suzuki, Hiroyoshi ^a   Ohto, Takashi ^a,b   Iwasaki, Yuzo ^c   Sakurai, Yoshiharu ^a   Ucnohara, Hiroshi ^a   Suzuki, Shinsuke ^a   Takei, Hidehiro ^a   Tezuka, Fumiaki ^a  

^a SENDAI CITY MEDICAL CENTER   (Japan)

^b National Hospital Organization Fukushima Hospital   (Japan)

^c MIYAGI NATIONAL HOSPITAL   (Japan)

Author keywords

Cyclin D; Differential polymerase chain reaction,; Gene amplification; Glioma; Immunohistochemistry

Indexed keywords

CYCLIN D1; FORMALDEHYDE; MONOCLONAL ANTIBODY KI 67; PARAFFIN;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LABELING INDEX; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031686581     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.1998.tb00114.x     Document Type: Article

References (15)

1. He J, Olson JJ, James CD. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 1995; 55:4833-4836.
2. Ono Y, Tamiya T, Ichikawa T et al. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neural 1996; 55:1026-1031.
3. Collins VP. Gene amplification in human gliomas. Glia 1995; 15:289-296.
4. Reifenberger G, Reifenberger J, Ichimura K, Collins VP. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site. Cancer Res 1995; 55:731-734.
5. Henson JW, Schnitker BL, Correa KM et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neural 1994; 36:714-721.
6. Hunter T, Pines J. Cyclins and cancer. Cell 1991; 66: 1071-1074.
7. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin Dl protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9:707-718.
8. Lukas J, Aagaard L, Strauss M, Bartek J. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 1995; 55:4818-4823.
9. Pines J. Cyclins, CDKs and cancer. Semin Cancer Biol 1995; 6:63-72.
10. Dirks PB, Hubbard SL, Murakami M, Rutka JT. Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J Neuropathol Exp Neural 1997; 56:291-300.
11. Chakrabarty A, Bridges LR, Gray S. Cyclin D1 in astrocytic tumours: An immunohistochemical study. Neuropathol Appl Neurobiol 1996; 22:311-316.
12. Frye RA, Benz CC, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989; 4:1153-1157.
13. Gramlich TL, Fritsch CR, Maurer D, Eberle M, Gansler TS. Differential polymerase chain reaction assay of cyclin Dl gene amplification in esophageal carcinoma. Diagn Mol Pathol 1994; 3:255-259.
14. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumor of the central nervous system. In: Sobin LH (ed.). World Health Organization International Histological Classification of Tumors, 2nd edn. Geneva: Springer-Verlag; 1993.
15. Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 1997; 7: 871-875.